Verition Fund Management 13F: Cuts AXTA Stake by $17M
Verition Fund Management reduced its investment in Axalta Coating Systems Ltd. NYSE:AXTA by more than half during the period.
Reviewed by automated data checks against the source filing. How we make and check alerts
Verition Fund Management sold 499,794 shares from its stake in Axalta Coating Systems Ltd. ($AXTA), a 51.22% decrease, according to a 13F filing with the SEC dated May 15, 2026. It reported 475,990 shares worth $16.16 million at the end of the quarter.
Since the filing, $AXTA is up 9.0% after 1 week, up 26.0% after 1 month and up 24.7% to date (from the $26.81 close on May 15, 2026).
Find the original: Verition Fund Management 13F filings on SEC EDGAR
Key Points
- Verition Fund Management cut its position in Axalta Coating Systems Ltd. NYSE:AXTA by 51.2%, shedding 499,794 shares during the reporting period.
- The fund finished the period holding 475,990 shares of the specialty chemicals maker, valued at roughly $16.2 million based on recent disclosures.
- Axalta shares trade near $33.95, backed by a price-to-earnings ratio of 19.5 and a consensus buy rating from Wall Street analysts.
Get $AXTA trade alerts by text
We text you when insiders, Congress or big funds trade $AXTA. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Axalta Coating Systems Ltd. alert may contain errors. Disclosures
Verition Fund Management Trims Axalta Position
Verition Fund Management pared back its exposure to Axalta Coating Systems Ltd. NYSE:AXTA, cutting its holdings by more than half according to a recent Form 13F filing with the Securities and Exchange Commission. The institutional investor dropped 499,794 shares during the period, leaving it with 475,990 shares of the specialty chemicals provider. The remaining stake carried an estimated value of $16.2 million at the close of the reporting window.
Inside the Reduction at Axalta Coating Systems
The sizeable adjustment lowered Verition's prior share count of 975,784 shares by a 51.2% margin. Institutional filings like this one offer a backward-looking snapshot of portfolio adjustments made as of the end of the reporting period and do not necessarily reflect current trading activity. Quantitative and multi-strategy funds routinely adjust holdings across hundreds of positions to rebalance risk, manage sector exposures, or lock in gains following price moves.
Axalta Shares and Market Standing
Axalta shares trade near $33.95, sitting comfortably between its 52-week low of $24.94 and high of $38.61. The company carries a market capitalization of roughly $6.82 billion and a price-to-earnings ratio of 19.5. Fundamental metrics show a trailing earnings per share of $1.63 alongside a forward price-to-earnings ratio of 11.1, pointing to expected earnings growth ahead for the Philadelphia-based materials supplier.
Wall Street Analyst Views on Axalta
Wall Street firms maintain an active coverage map for the stock, featuring a consensus buy recommendation and a mean price target of $39.33. On October 13, 2026, Barclays initiated coverage with an Overweight rating and a $45.00 price target. Earlier in the autumn, on October 5, 2026, UBS maintained its Neutral rating while adjusting its price target to $36.00 from $39.00. Keybanc also started coverage on September 11, 2026, assigning an Overweight rating and a $47.00 price target.
Overview of Axalta Coating Systems Operations
Axalta manufactures and distributes high-performance liquid and powder coatings for industrial, commercial, and automotive applications worldwide. Operating through performance and mobility segments, the company supplies refinish products to independent body shops alongside original equipment manufacturer coatings for vehicles, building materials, and wood products. The firm was founded in 1866 and maintains its headquarters in Philadelphia, Pennsylvania.
What to Watch Next for Axalta
Investors tracking Verition's portfolio strategy and Axalta's broader market trajectory will look toward the company's next earnings report scheduled for October 28, 2026. Future SEC filings will clarify whether other institutional managers followed a similar path or maintained their stakes in the chemical maker.
Source: Verition Fund Management's 13F filing on $AXTA (May 15, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Verition Fund Management 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts